4DX

0.95%

52.0¢ 4dmedical limited

Ann: Trading Halt, page-18

First 18 Last

Share
Profile

Follow
Cidkiddd94

383 Posts.

45

07/12/23

09:38

Post #: 71318377
Share

Originally posted by MikesLM: ↑

Let's trust in AF and management to make strategic acquisitions at the appropriate time to accelerate growth for the long term.

Imbio is growing very quickly and is cash-flow positive and probably wouldn't go for this price next year or the year after when its revenue is much higher (and potential profitability) and the acquisition would probably significantly enhance 4DMedical's products and company's profile.

Imbio would also have a large customer list that we can leverage to upsell 4DMedical's suite / pipeline of products.

If you look at Imbio's product suite, you will see a large array of lung analysis products (and FDA cleared where applicable). And a heart product (coronary artery analysis) too!

At first sight and when you see capital raise it might sound curious as to "why", but when you look further (and I'm sure the company will fully explain this), you will find that this is money very well spent for A$30m (and potentially cheap on a LT basis). If you think about the money we would need to spend to conduct R&D to produce or reproduce all these products and then money to achieve FDA approvals for the products and then the marketing/commercialisation costs to get the company to $9m revenue per year and growing at 112 per cent, you'd see that this is great value for money!!

We are also taking out potential similar competition. Remember PME acquired Visage and turned that into a real money spinner and to the company of its multi billion dollar market cap. It also makes sense why we met Minnesota governor and trade delegation in Melbourne recently.

All in all, after reflecting about this with high level research, and keen to see the company's presentation on the rationale, I think investors should see this as a very good acquisition, and potentially material/game-changing for the company's sustainable future.

Expand

110% agree with you.
Already at profitability at a growth rate of 112%, which 4D could increase that growth rate whilst accelerating 4D's reach and customer base.
I think it's a very good move. AF knows

4DX Price at posting: 95.5¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump is President Again: What Does This Mean for Crypto?

IMU

Imugene kicks off Australian trial for blood cancer treatment

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

HotCopper Highlights: Your most watched and most discussed stocks this week

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

There are more pages in this discussion • 103 more messages in this thread...

First 18 Last

Add 4DX (ASX) to my watchlist

(20min delay)
Last 52.0¢		Change -0.005(0.95%)		Mkt cap ! $213.4M

Open	High	Low	Value	Volume
52.0¢	53.5¢	51.0¢	$175.2K	337.1K

Buyers (Bids)

No.	Vol.	Price($)
6	173020	51.0¢

Sellers (Offers)

Price($)	Vol.	No.
52.0¢	162258	3

View Market Depth

No.	Vol.	Price($)
5	124001	0.510
2	20417	0.505
12	137800	0.500
1	750	0.495
2	55081	0.490

Price($)	Vol.	No.
0.520	162258	3
0.535	15160	2
0.540	43833	4
0.545	10000	1
0.550	15010	3

Last trade - 16.10pm 08/11/2024 (20 minute delay)

4DX (ASX) Chart

Ann: Trading Halt, page-18

Universal Biosensors flat despite fresh deal with US medical product distributor

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump is President Again: What Does This Mean for Crypto?

Imugene kicks off Australian trial for blood cancer treatment

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Flynn Gold reaches milestone exploration target for Golden Ridge

HotCopper Highlights: Your most watched and most discussed stocks this week

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-18

Top Stories

Universal Biosensors flat despite fresh deal with US medical product distributor

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump is President Again: What Does This Mean for Crypto?

Imugene kicks off Australian trial for blood cancer treatment

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Flynn Gold reaches milestone exploration target for Golden Ridge

HotCopper Highlights: Your most watched and most discussed stocks this week

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News